• vcard
  • Education
    • J.D., Northeastern University School of Law-Boston
    • Ph.D., Baylor College of Medicine, Pharmacology
    • B.S., Fudan University, Biochemistry
  • Bar Jurisdictions
    • Massachusetts
    • Admitted to practice before the United States Patent and Trademark Office

Dr. Jenny Chen counsels both U.S. and international clients in a wide-array of patent-related matters in the Biotech and Life Science space, including prosecution, opinion, due diligence, licensing and post-grant proceedings. Her practice focuses on matters including biosimilars, antibodies, cell therapies, gene therapies, diagnosis and pharmaceutical formulations. She is particularly experienced in strategic counseling on life cycle management of both biological and small molecule products.

Dr. Chen leverages an in-depth understanding of the industries in which clients work. Prior to joining Polsinelli, Dr. Chen served as a postdoctoral fellow in the laboratory of Dr. David Hafler at Brigham & Women’s Hospital, Harvard Medical School. Her research focused on T cell activity in autoimmune diseases such as Type I diabetes. Dr. Chen received her Ph.D. from Baylor College of Medicine, with a focus in molecular biology and pharmacology.

  • Assisted leading academic institution in securing patent protection for diagnostic test expected to be used on millions of patients in determining risks for adverse drug reactions
  • Built world-wide patent portfolios covering an antibody product, which obtained marketing approval in various countries
  • Conducted clearance analysis in connection with clients’ contemplated generic and biosimilar drug marketing
  • Conducted due diligence studies on patent landscape and market exclusivity in connection with biotech transaction
  • Successfully demonstrated continuous diligence for an 11-month period in an interference proceeding
text icon Publications & Presentations
Quoted, Law 360
April 26, 2019
text icon Publications & Presentations
Opting for PGR over IPR: A Cautionary Tale
Author, IP Litigator
December 15, 2016